Anna joined IQVIA’s Price Regulation Consulting team in 2019. A strategic thinker in market access and pricing, Anna has over a decade of experience in the pharmaceutical industry.
Prior to joining IQVIA, Anna was responsible for leading market access initiatives and for managing pricing and reimbursement strategies at various leading pharmaceutical companies. She also has worked in business development, pharmacovigilance, health economics and sales.
She holds a bachelor’s degree in Biomedical Sciences and a MSc in Pharmaceutical Science from Université de Montréal.
Agenda: Day 1 Oct 5, 2020
PMPRB ’22 GUIDELINES – WHAT DO WE KNOW SO FAR? SPECIAL Q&A
The PMPRB released its revised draft Guidelines on October 6th, making big news for the industry! Gain a better understanding of the details to prepare your senior management team both in Canada and internationally. Take away new perspectives and deepen your knowledge on:
- How the guidelines have been ‘updated’ given previous litigation
- Is what was formerly a ‘competition bureau’ approach applicable to drug pricing?
- What does TRUE access mean?
- Which arguments are acceptable in the face of future manufacturer investigations?
Set yourself up for success with answers to your toughest PMPRB questions.
Agenda: Day 2 Oct 6, 2020